Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada · Delayed Price · Currency is CAD 0.1000
-0.0050 (-4.76%)
At close: Mar 20, 2026
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of CAD 10.89 million as of March 20, 2026. Its market cap has decreased by -45.16% in one year.
Market Cap
10.89M
Enterprise Value
9.99M
Revenue
754.64K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 6.64M to 10.89M, an increase of 64.06%. That is a compound annual growth rate of 12.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 10.89M | -9.05% |
| Dec 31, 2025 | 11.98M | -53.64% |
| Dec 31, 2024 | 25.84M | 112.35% |
| Dec 29, 2023 | 12.17M | 486.37% |
| Dec 30, 2022 | 2.07M | -68.75% |
| Jan 11, 2022 | 6.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lobe Sciences | 18.86M |
| Britannia Life Sciences | 15.41M |
| Hemostemix | 13.67M |
| Rapid Dose Therapeutics | 13.52M |
| PreveCeutical Medical | 11.96M |
| Quantum BioPharma | 11.93M |
| Marvel Biosciences | 9.77M |
| Glow Lifetech | 9.08M |